The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Clinical & ResearchFull Access

Article on Dismantling Racism in Psychiatry Among 2021 AJP Editor’s Picks

Published Online:https://doi.org/10.1176/appi.pn.2022.2.20

Abstract

The editors of the American Journal of Psychiatry (AJP) have vowed to use the journal to combat structural racism and health care inequities.

Photo: Cover of the American Journal of Psychiatry

It has been a longstanding tradition for the editors of the American Journal of Psychiatry to close out each year with a selection of articles from the previous year that rose above the rest.

“One of the most important and relevant articles that we published [in 2021] in the Journal is a call to action for psychiatry to confront and change the structural racism framework that significantly contributes to mental health care inequities,” wrote AJP Editor-in-Chief Ned Kalin, M.D., in the editorial “2021 Articles of Import and Impact” in the January issue.

The article Kalin was referring to was titled “Dismantling Structural Racism in Psychiatry: A Path to Mental Health Equity” by Ruth S. Shim, M.D., M.P.H. Shim is the Luke & Grace Kim Professor in Cultural Psychiatry at the University of California, Davis.

Shim opened the review with an examination of the meaning of the terms race, structural racism, social injustice, health disparities, and health inequities.

AJP Editor’s Picks for 2021

  • Dismantling Structural Racism in Psychiatry: A Path to Mental Health Equity. Ruth S. Shim.

  • Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial. Sarah Costi et al.

  • Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial. Lara A. Ray et al.

  • Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia. Yash B. Joshi et al.

  • A Longitudinal Study of Resting-State Connectivity and Response to Psychostimulant Treatment in ADHD. Luke J. Norman et al.

  • Effect of Experimental Manipulation of the Orbitofrontal Cortex on Short-Term Markers of Compulsive Behavior: A Theta Burst Stimulation Study. Rebecca B. Price et al.

  • Differential Patterns of Delayed Emotion Circuit Maturation in Abused Girls With and Without Internalizing Psychopathology. Taylor J. Keding et al.

  • Adrafinil: Psychostimulant and Purported Nootropic? Danielle W. Lowe et al.

Editor summaries for all “2021 Articles of Import and Impact” are posted here.

“While health disparities are differences in health status among distinct segments of the population, health inequities are defined as disparities in health that are a result of systemic, avoidable, and unjust policies and practices that create barriers to opportunity,” she wrote. “By describing the cause or origin of these differences in health, the definition of inequities is more precise. Because the term disparities does not identify the cause of the difference, there is a tendency to default to traditional and historical explanations for difference, which include seating the pathology with an individual or a population.”

Also captured in Shim’s article are the ways that policies that led to residential segregation beginning in the 1930s, and the War on Drugs in the 1980s have impacted and continue to impact the mental health of people of color.

“[A]s a result of residential segregation, psychiatrists and therapists were (and are) less likely to be located in low-income neighborhoods with greater percentages of Black and Latinx residents (when compared with high-income neighborhoods with less than 1% of Black or Latinx residents),” Shim wrote. “The structurally racist policies of the War on Drugs have led to the mass incarceration of people of color for substance use disorders.”

Shim concluded her piece with suggestions for how psychiatry can begin to dismantle the legacy of structural racism and advance mental health equity for all. There are immediate actions that mental health professionals can take, she noted, such as observing and challenging their own biases, enforcing social norms of inclusion and equity in personal and professional settings, and advocating for policies that may appear to not be directly related to mental health but are critical for it to succeed: stable housing, unemployment benefits, and access to healthy food.

“Because psychiatrists and other mental health professionals desire to promote the mental health and well-being of all people, we all have a moral responsibility to speak out against racial injustice wherever we encounter it, recognizing, in the words of Frederick Douglass, that ‘power concedes nothing without a demand,’ ” Shim concluded.

Four AJP Studies Recognized by BBRF

AJP’s commitment to publishing cutting-edge and clinically relevant research was recognized by the Brain & Behavior Research Foundation (BBRF) this past year. (BBRF President and CEO Jeffrey Borenstein, M.D., is the editor in chief of Psychiatric News.) Four AJP studies were cited among BBRF’s leading research achievements in 2021 (the most of any journal). These include the following:

  • A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder. Adriana Feder et al.

  • Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia. Yash B. Joshi et al.

  • Neonatal Brain Response to Deviant Auditory Stimuli and Relation to Maternal Trait Anxiety. Chad M. Sylvester et al.

  • Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial. Eleanor J. Cole et al.

A list of BBRF’s 2021 Leading Research Achievements is posted here.

Also recognized in the editor’s picks for 2021 were studies that highlighted potential new treatments for depression and compulsive behaviors, called attention to medication-related cognitive impairments in schizophrenia, and provided insight into brain development in girls who were abused (see box). But the promise offered by such research cannot be truly fulfilled unless everyone can benefit equally, Kalin noted.

“As we avowed earlier in the Journal, the deputy editors and I have made the commitment to use the American Journal of Psychiatry as a means to combat structural racism and health care inequities,” Kalin wrote in his summary of Shim’s article. “We are specifically focused on improving mental health care for individuals of color and more broadly for individuals from underprivileged and discriminated communities. We thank Dr. Shim for moving us forward in this direction, as we enthusiastically continue in our pursuit of this critical goal.” ■

“Dismantling Structural Racism in Psychiatry: A Path to Mental Health Equity” is posted here.